Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
4.000
-0.190 (-4.53%)
Jul 19, 2024, 12:00 AM EDT - Market open
Telesis Bio Employees
As of December 31, 2023, Telesis Bio had 147 total employees, including 137 full-time and 10 part-time employees. The number of employees decreased by 96 or -39.51% compared to the previous year.
Employees
147
Change (1Y)
-96
Growth (1Y)
-39.51%
Revenue / Employee
$167,571
Profits / Employee
-$320,592
Market Cap
6.69M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 147 | -96 | -39.51% |
| Dec 31, 2022 | 243 | 7 | 2.97% |
| Dec 31, 2021 | 236 | 145 | 159.34% |
| Dec 31, 2020 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CareMax | 1,450 |
| Sunshine Biopharma | 44 |
| ReShape Lifesciences | 29 |
| Pasithea Therapeutics | 8 |
| Tenax Therapeutics | 6 |
| Cadrenal Therapeutics | 4 |
| Xenetic Biosciences | 4 |
| Alaunos Therapeutics | 1 |
TBIO News
- 2 months ago - Telesis Bio Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Telesis Bio Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership - GlobeNewsWire
- 4 months ago - Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results - GlobeNewsWire
- 8 months ago - Telesis Bio Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 9 months ago - Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023 - GlobeNewsWire
- 9 months ago - Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA - GlobeNewsWire